Diagnostic Utility of Markers in Prostate Cancer
Author Information
Author(s): Kumaresan K, Kakkar Nandita, Verma Alka, Mandal Arup Kumar, Singh Shrawan Kumar, Joshi Kusum
Primary Institution: Post Graduate Institute of Medical Education and Research, Chandigarh, India
Hypothesis
To evaluate the diagnostic utility of alpha-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer.
Conclusion
A combination of HMWCK and AMACR significantly increases the diagnostic accuracy in prostate cancer.
Supporting Evidence
- 49 out of 50 suspicious cases were resolved using both markers.
- 30% of suspicious cases had their diagnosis changed from benign to malignant.
- Overall diagnosis changed in 1.64% of prostatic disease cases.
Takeaway
Doctors used special markers to help tell if prostate cancer is present in tricky cases, and they found it really helps.
Methodology
Reviewed 1034 prostate cases, categorized them, and performed immunohistochemistry on suspicious cases.
Limitations
The study acknowledges the pitfalls and limitations of the markers used.
Participant Demographics
Age ranged from 48 to 85 years; included various types of prostate specimens.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website